Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • FALSE CLAIMS ACT—N.D. Ga.: Relators win $1.9M fee fight after hospice parties seek reduction for unsuccessful claims
    • ENFORCEMENT ACTIONS—NOTICES: FDA permanently debars oncologist over illegal cancer drug resale scheme
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FOOD STANDARDS—PROPOSED RULES: FDA receives petition to expand calcium sulfate color additive uses
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • GENERAL HEALTH CARE NEWS—NOTICES: HRSA extends funding for 272 health centers pending 2027 awards
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • LABELING AND PACKAGING (FOOD, DRUGS & MEDICAL DEVICES)—E.D.N.Y.: Putative class action over broth protein labeling is ruled preempted by federal law
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—GAO REPORTS: GAO report urges FDA to address gaps in audit policies for device review program
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • REGULATION TRACKER—Information on pending or recently adopted regulations and regulation amendments
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, ENFORCEMENT ACTIONS—NOTICES: FDA permanently debars oncologist over illegal cancer drug resale scheme, (Sep 28, 2026)

    By WK Editorial Staff

    FDA permanently barred a Michigan oncologist from working with companies holding approved or pending drug applications after a felony conviction stemming from the unlawful resale of prescription cancer drugs.

    The FDA issued a final order permanently d ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use